FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.12.1219",
  "meta": {
    "versionId": "17",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2017-05-04"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1219",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1219"
    }
  ],
  "version": "20170504",
  "name": "InactivatedPolioVaccineIPV",
  "title": "Inactivated Polio Vaccine (IPV)",
  "status": "active",
  "experimental": false,
  "date": "2017-05-04T01:00:13-04:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for immunizations with inactivated polio vaccines (IPV).),(Data Element Scope: This value set may use a model element related to Immunization.),(Inclusion Criteria: Includes concepts that represent an inactivated polio vaccine (IPV).),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1222"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:66d11d55-aef5-4d75-a15c-e98d15074109",
    "timestamp": "2025-05-23T22:32:02-04:00",
    "total": 5,
    "contains": [
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "10",
        "display": "poliovirus vaccine, inactivated"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "110",
        "display": "DTaP-hepatitis B and poliovirus vaccine"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "120",
        "display": "diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "146",
        "display": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine."
      },
      {
        "system": "http://hl7.org/fhir/sid/cvx",
        "version": "20250502",
        "code": "89",
        "display": "poliovirus vaccine, unspecified formulation"
      }
    ]
  }
}